SPONSOR
Guangdong Hengrui Pharmaceutical Co., Ltd
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 1
Conditions studied: Systemic Lupus ErythematosusModerate-to-severe Inflammatory Bowel DiseaseIPF and PPF
Guangdong Hengrui Pharmaceutical Co., Ltd is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Systemic Lupus Erythematosus, Moderate-to-severe Inflammatory Bowel Disease, IPF and PPF.
The trial portfolio spans Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Guangdong Hengrui Pharmaceutical Co., Ltd
How many clinical trials has Guangdong Hengrui Pharmaceutical Co., Ltd sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Guangdong Hengrui Pharmaceutical Co., Ltd, of which 3 are actively recruiting participants. These trials cover conditions including Systemic Lupus Erythematosus, Moderate-to-severe Inflammatory Bowel Disease, IPF and PPF. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Guangdong Hengrui Pharmaceutical Co., Ltd research focus on?
Guangdong Hengrui Pharmaceutical Co., Ltd clinical trials span Systemic Lupus Erythematosus, Moderate-to-severe Inflammatory Bowel Disease, IPF and PPF. The research pipeline includes Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Guangdong Hengrui Pharmaceutical Co., Ltd clinical trial?
To participate in a Guangdong Hengrui Pharmaceutical Co., Ltd trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Guangdong Hengrui Pharmaceutical Co., Ltd trials with current recruitment status updated daily.
Clinical Trials by Guangdong Hengrui Pharmaceutical Co., Ltd
NCT07299422 Phase 2
Recruiting
A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
NCT07758101 Phase 1
Recruiting
A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-severe Inflammatory Bowel Disease
Moderate-to-severe Inflammatory Bowel Disease
NCT07192939 Phase 2
Recruiting
Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary Fibrosis
IPF and PPF
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology